Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Account Payables (2019 - 2025)

Historic Change in Account Payables for IDEAYA Biosciences (IDYA) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • IDEAYA Biosciences' Change in Account Payables rose 13023.61% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 734.86%. This contributed to the annual value of $8.3 million for FY2024, which is 21423.15% up from last year.
  • As of Q3 2025, IDEAYA Biosciences' Change in Account Payables stood at $1.2 million, which was up 13023.61% from -$364000.0 recorded in Q2 2025.
  • In the past 5 years, IDEAYA Biosciences' Change in Account Payables ranged from a high of $9.7 million in Q2 2024 and a low of -$3.9 million during Q3 2024
  • Its 5-year average for Change in Account Payables is $921052.6, with a median of $397000.0 in 2022.
  • Per our database at Business Quant, IDEAYA Biosciences' Change in Account Payables soared by 577142.86% in 2022 and then plummeted by 367500.0% in 2024.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Change in Account Payables stood at -$7000.0 in 2021, then soared by 5771.43% to $397000.0 in 2022, then surged by 339.55% to $1.7 million in 2023, then skyrocketed by 70.54% to $3.0 million in 2024, then plummeted by 59.98% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, -$364000.0 for Q2 2025, and $2.7 million during Q1 2025.